| Literature DB >> 15556493 |
Nobuhiro Ohtake1, Yoichiro Nakai, Masahiro Yamamoto, Iwao Sakakibara, Shuichi Takeda, Sakae Amagaya, Masaki Aburada.
Abstract
Sho-saiko-to (SST) was introduced into Japan as an oriental classical medicine from China approximately 1500 years ago, and it is currently the most representative Kampo medicine (traditional Japanese medicine). SST is manufactured in Japan as an ethical drug on a modern industrial scale in which the quality of ingredients is standardized with Good Manufacturing Practices (GMP) regulation. SST is widely used for the treatment of chronic hepatitis. Experimental and clinical studies including multi-center, placebo-controlled, double-blind studies have demonstrated the various pharmacological effects of SST. SST is prepared from the hot water extraction of seven raw materials, therefore many kinds of constituents are included. Three-dimensional (3D) HPLC analysis is useful for obtaining many kinds of constituents, especially low molecular ultraviolet (UV) quenching compounds, contained in SST as well as its fractions. Fingerprint pattern provided by 3D HPLC analysis makes possible to identify the overall-viewing of SST. Databases of UV spectra of the components of medicinal herbs obtained by reversed-phase (RP) HPLC using a photodiode array (PDA) and fingerprint patterns of crude drugs made by 3D HPLC analysis facilitate the identification, analysis and quality of herbal drugs. Studies using both PDA HPLC and an amino acid analysis with a fluorometric detector have found that SST contains fifteen major low molecular compounds (i.e. baicalin, wogonin-7-O-glucuronide, liquiritin, their three aglycons, liquiritin apioside, glycyrrhizin, saikosaponin b1, saikosaponin b2, ginsenoside Rg1, ginsenoside Rb1, (6)-gingerol, (6)-shogaol and arginine). These compounds have various pharmacological actions, and are assumed to be responsible, at least partly, for the pharmacological effects of SST. Although there have only been a few investigations on high molecular compounds with pharmacological actions contained in SST, several kinds of polysaccharides have been isolated from constituent herbs of SST. This review paper summarizes analytical methods of separation, isolation and identification of compounds with biological activities from SST, which is a mixture drug of medicinal herbs. Accordingly, this paper would not focus on methods of separation, isolation and analysis of particular compounds from each constituent herb of SST.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15556493 PMCID: PMC7105231 DOI: 10.1016/j.jchromb.2004.06.051
Source DB: PubMed Journal: J Chromatogr B Analyt Technol Biomed Life Sci ISSN: 1570-0232 Impact factor: 3.205
Different classes of compounds contained in the standardized Sho-saiko-to (SST) [133]
| Class of compounds | Content (%) |
|---|---|
| Starch, polysaccharides | 31.5 |
| Oligo-/monosaccharides | 24.7 |
| Organic compounds | 21.9 |
| Nitrogenated compounds | 8.9 |
| Free amino acids | 4.8 |
| Ash | 4.5 |
| Water, solvent | 3.4 |
| Lipids | 0.1 |
| Fiber | 0.2 |
Other than nitrogenated compounds and sugars.
Biologically active compounds in the constituent herbs of SST
| Constituent herb | Low molecular mass compounds | High molecular mass compounds |
|---|---|---|
| Bupleurum Radix | (1) Saikosaponin a | (1) Bupleuran 2 |
| (2) Saikosaponin c | ||
| (3) Saikosaponin d | ||
| (4) Arginine | ||
| Pinelliae Tuber | (1) PTH | (1) Pinellian G |
| (2) PTH | (2) Pinellian PA | |
| Scutellariae Radix | (1) Baicalin | |
| (2) Baicalein | ||
| (3) Wogonin-7- | ||
| (4) Wogonin | ||
| (5) Skullcapflavone II | ||
| (6) Daidzein, | ||
| (7) Arginine | ||
| Zizyphi Fructus | (1) Ethyl α- | (1) Polysaccharide of MW: 1.2 × 105 |
| (2) Polysaccharide of MW: 43,000 | ||
| Ginseng Radix | (1) Ginsenoside R0 | (1) Ginsenan PA |
| (2) Ginsenoside Rb1 | (2) Ginsenan PB | |
| (3) Ginsenoside Rb2 | (3) Ginsenan S-IIA | |
| (4) Ginsenoside Rb3 | (4) Ginsan | |
| (5) Ginsenoside Re | ||
| (6) Ginsenoside Rg1 | ||
| (7) Ginsenoside Rg2 | ||
| (8) 20(S)-Ginsenoside Rg3 | ||
| (9) Δ20-Ginsenoside Rg3 | ||
| (10) Ginsenoside Rh2 | ||
| (11) Ginsenoside Rf | ||
| (12) Panaxynol | ||
| (13) Arginine | ||
| Glycyrrhizae Radix | (1) Liquiritin | |
| (2) Liquiritin apioside | ||
| (3) Liquiritigenin | ||
| (4) Isoliquiritin | ||
| (5) Isoliquiritin apioside | ||
| (6) Isoliquiritigenin | ||
| (7) Glycyrrhizin | ||
| (8) Glycyrrhizic acid | ||
| (9) Glycycoumarin | ||
| (10) Genistein | ||
| (11) Licopyranocoumarin | ||
| (12) Licocoumarone | ||
| (13) Glycyrrhisoflavone | ||
| Zingiberis Rhizoma | (1) (6)-Shogaol | |
| (2) (6)-Gingerol | ||
| (3) (8)-Gingerol | ||
| (4) Zingerone | ||
| (5) Zingiberene | ||
| (6) 6-Gingesulfonic acid, | ||
| (7) Gingerglycolipid A | ||
| (8) Gingerglycolipid B | ||
| (9) Gingerglycolipid C | ||
| (10) β-Bisabolene, | ||
| (11) Arcurcumene | ||
PTH-15 and PTH-16 were flavoniods reported by Maruno [134].
HPLC method for determination of the compounds in SST
| (1) | SST was extracted with 50% methanolic water under ultrasonication for 30 min, followed by centrifugation |
| (2) | Analysis of the supernatant solution was performed with an HPLC apparatus equipped with two pumps, a photodiode-array (PDA) detector, an evaporative light scattering (ELS) detector and an 5 μm 250 × 4.6 mm ODS column (ODS-80Ts, TOSOH, Tokyo, Japan) placed in a column oven |
| (3) | The mobile phase was a mixture of (A) 3 mM CF3COOH aq. and (B) 100% CH3CN with a linear gradient changing rate from 90% A and 10% B to 100% B over 60 min, and then 100% B was continued for 20 min |
| (4) | The flow rate of the mobile phase was 1.0 ml/min and the column temperature was 40 °C |
| (5) | The UV data of the effluent from the column ranging from 200 to 400 nm were collected, and peak analysis and assignment were performed with the system analysis software (CLASS-LC10, Shimadzu, Kyoto, Japan) |
| (6) | Regarding peak identification by the PDA detector, it was conducted according to the method reported by Mito and Kitaoka |
Fig. 1ELSD/PDA-HPLC profiles of SST and UV–vis absorption spectra of baicalin, glycyrrhizin, and saikosaponin b2 obtained by a PDA detector. The procedure of HPLC analysis of SST is described in Table 3. HPLC profile with ELS detector (A), 3D HPLC analysis profile with PDA detector (B), UV–vis absorption spectra of compounds (C).
Fig. 2Method of separation of pharmacologically active ingredients in SST.
Method of separation of major low molecular compounds (LMC) from S-fraction
| (1) | 100 g of S-fraction dried powder was dissolved in 5000 ml water, and this was applied to a column on which 5000 g Diaion HP20 had been packed |
| (2) | The adsorbed S-fraction with Diaion HP20 was successively eluted with 5000 ml of water, 5000 ml of 50% aqueous methanol and 5000 ml of 100% methanol |
| (3) | Each elution was evaporated to dryness |
Method of separation of major low molecular compounds (LMC) from M fraction
| (1) | M dried powder was dissolved in 50% MeOH, and this was applied to a Sephadex LH-20 column rinsed with 50% MeOH |
| (2) | Gradient RP-HPLC from 50% MeOH to MeOH, to obtain three fractions, i.e. flavonoids, saponins and its mixture |
| (3) | 35% MeOH solution of the flavonoids–saponins mixture was applied to the ODS column that had been rinsed with 35% MeOH |
| (4) | Gradient RP-HPLC from 35% MeOH to MeOH, to obtain two fractions, flavonoids and saponins |
| (5) | Each saponins fraction and flavonoids fraction is collected to dryness |
| (6) | M-saponins were extracted with diethyl ether under sonication |
| (7) | The extract was filtered and concentrated to afford M-phenylalkanoid fractions |
HPLC method for isolation and analysis of compounds in 50M and three fractions (M-flavonoids, M-saponins and MS-pa) that had been separated from M fraction
| (1) | Each fraction was extracted with methanol under ultrasonication for 30 min, followed by centrifugation |
| (2) | Analysis of the supernatant solution was performed with an HPLC apparatus (Shimadzu, Kyoto, Japan) equipped with two pumps, a photodiode-array (PDA) detector and an ODS column placed in a column oven |
| (3) | The mobile phase was a mixture of (A) 20 mM H3PO4 aq. and (B) 100% CH3CN with a linear gradient rate of 90% A and 10% B changing over 60 min to 100% B. Then 100% B was continued for 20 min |
| (4) | The flow rate of the mobile phase and the column temperature were 1.0 ml/min or 40 °C, respectively |
| (5) | The UV data of the effluent from the column ranging from 200 to 400 nm were collected, and the peak analysis and assignment were performed with the system analysis software (CLASS-LC10, Shimadzu, Kyoto, Japan) |
This is a partial modification of the method reported by Nakai et al. [136].
Fig. 3Three-dimensional (3D) HPLC analysis profiles of the 50M fraction separated from SST. The chromatographic conditions are described in Table 6.
Fig. 4Three-dimensional (3D) HPLC analysis profiles of the M-flavonoids fraction. The chromatographic conditions are described in Table 6.
Fig. 5Structures of the detected compounds in the 50M and M-flavonoids fractions. 1, glc is a d-glucopyranonose; 2, api is a d-apiofuranose; 3, glcA is a d-glucuronic acid.
Fig. 6Three-dimensional (3D) HPLC analysis profiles of the M-saponins fraction. The chromatographic conditions are described in Table 6.
Fig. 7Structures of the detected compounds in the M-saponins fraction. 1, glcA is a d-glucuronic acid; 2, glc is a d-glucopyranonose; 3, fuc is a fucose.
Fig. 8Three-dimensional (3D) HPLC analysis profiles of the MS-pa fraction. The chromatographic conditions are described in Table 6.
Fig. 9Structures of the detected compounds in the MS-pa fraction.
Analytical method for amino acids
| (1) | The W fraction was extracted with 0.2N sodium-citrate–HClO4 buffer (pH 2.2) under ultrasonication for 30 min |
| (2) | The solution is obtained after centrifugation at 3000 rpm at room temperature for 10 min, and the supernatant was filtered through a 0.45 μm membrane |
| (3) | HPLC on a 5 μm, 100 mm × 6 mm cation exchange polymer column (AApack Na, Jasco, Tokyo, Japan), 0.6 ml/min with next eluent program |
| (a) pH 2.97 | |
| (b) pH 3.28 | |
| (c) pH 4.25 | |
| (d) pH 3.75 | |
| (e) pH 4.55 | |
| (4) | The fluorometric data of the effluent from the column were obtained with excitation at 350 nm and emission at 440 nm in under the reaction condition of post reaction systems (a temperature reaction coil (TJ-100, Jasco, Tokyo, Japan) with both a flow rate reagents ( |
Fig. 10HPLC profiles of the amino acids in the W fraction of SST. The chromatographic analysis conditions are described in Table 7. The HPLC profile of the W fraction mainly shows the presence of arginine.
Chemical properties of fraction 12
| Molecular weight | 1.2 × 105 |
| Total protein (as BSA | ND |
| Total carbohydrate (as Glc) (%) | 70.2 |
| Total uronic acid (as GlcA) (%) | 40.4 |
Fraction 12 from SST was reported to have augmentation of NK activity [17].
Bovine serum albumin.
Not detected.
Pharmacological activities of high molecular compounds in the constituent herbs of SST
| Constituent herb | Name of compound | MW | Pharmacological activity | Reference |
|---|---|---|---|---|
| Bupleurum Radex | Bupleuran 2IIc | 6.3 × 103 | Anti-ulcer | |
| Pinelliae Tuber | Pinellian G | 1.5 × 104 | Anti-complement | |
| Pinellian PA | 11.8 × 104 | Anti-complement | ||
| Zizyphi Fructus | – (fraction 5) | 4.3 × 104 | Augmentation of NK activity | |
| Ginseng Radix | Ginsenan PA | 1.6 × 105 | Anti-complement | |
| Ginsenan PB | 5.5 × 104 | Anti-complement | ||
| Ginsenan S-IIA | 1.0 × 105 | Anti-complement | ||
Reports of both the phytochemical characters of a compound and its pharmacological activities.
HPLC detected compounds in fractions that had been separated from S-fraction
| W | 50M | M-flavonoids | M-saponins | MS-pa |
|---|---|---|---|---|
| Arginine, asparagines, etc. | Liquiritin, liquiritin apioside, baicalin, wogonin-7- | Baicalin, baicalein, wogonin, wogonin- | Glycyrrhizin, saikosaponin b1, saikosaponin b2, ginsenoside Rg1, ginsenoside Rb1 | (6)-Shogaol, (6)-gingerol |